Stockreport

It Looks Like Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO May Expect Their Salary To Be Put Under The Microscope [Yahoo! Finance]

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report
PDF Total compensation is 130% above industry average Milestone Pharmaceuticals' EPS declined by 9.8% over the past three years while total shareholder loss over the past [Read more]